SEELOS THERAPEUTICS INC (SEEL) Stock Analyst Ratings
NASDAQ:SEEL - Nasdaq - US81577F3073 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 86% to SEEL. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 122.4. This target is 9462.5% above the current price.
SEEL was analyzed by 7 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about SEEL.
In the previous month the buy percentage consensus was at a similar level.
SEEL was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-09-22 | Guggenheim | Downgrade | Buy -> Neutral |
| 2023-09-21 | Cantor Fitzgerald | Downgrade | Overweight -> Neutral |
| 2023-09-21 | Guggenheim | Downgrade | Buy -> Neutral |
| 2023-09-21 | Benchmark | Maintains | Speculative Buy -> Speculative Buy |
| 2023-08-22 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-08-15 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-06-23 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-06-23 | Benchmark | Reiterate | Speculative Buy -> Speculative Buy |
| 2023-05-16 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2023-05-15 | BTIG | Maintains | Buy -> Buy |
| 2023-03-24 | Benchmark | Maintains | Buy |
| 2021-09-27 | Roth Capital | Upgrade | Neutral -> Buy |
| 2021-08-10 | Roth Capital | Maintains | Neutral |
| 2021-07-01 | Guggenheim | Initiate | Buy |
| 2021-06-01 | Cantor Fitzgerald | Initiate | Overweight |
| 2021-03-30 | B. Riley FBR | Initiate | Buy |
| 2021-03-12 | BTIG | Initiate | Buy |